Trial intelligence / Profile preview

Double-blind intra-articular Allocetra versus placebo for thumb base osteoarthritis

MOH_2024-03-13_013310Phase 2Recruiting

Sponsor
ד"ר אמיר אורון
Start
May 2024
Modality
Cell Therapies
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of Allocetra in Rhizarthrosis and osteoarthritis (OA) (3 arms), sponsored by ד"ר אמיר אורון. Started May 2024; status: recruiting.

02

Drugs

Allocetra
03

Conditions

Rhizarthrosisosteoarthritis (OA)

Beyond the preview

Go deeper on MOH_2024-03-13_013310.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on MOH_2024-03-13_013310.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call